Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors: A Brief Review
Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors: A Brief Review
Yükleniyor...
Özet
Sodium-glucose co-transporter-2 inhibitors are novel antihyperglycemic agents which have crucial effects on the heart and kidneys beyond their glucose-lowering features. Their main clinical benefits have been reported in individuals with type 2 diabetes mellitus, chronic kidney disease, heart failure, and proteinuria. However, adverse reactions (euglycemic ketoacidosis, kidney dysfunction, genital and urinary tract infections, hypovolemia, etc) remain to be the main object of the debate regarding their use. The recruited data have encouraged clinicians to use those medicines in individuals who fit the indications for use.
Açıklama
Anahtar kelimeler
Medicine, Diabetes Mellitus, Diabetic Ketoacidosis, Dapagliflozin, Canagliflozin
Bilim Dalları
03 medical and health sciences, 0302 clinical medicine
Alıntı
WoS Q
Scopus Q
Cilt
1
Sayı
1
Başlangıç Sayfası
10
Bitiş Sayfası
13
Koleksiyonlar
Yükleniyor...
